Unsere News
27.04.2026
Nicole Ritz appointed as new Head of Research
Nicole Ritz will join Swiss TPH as the new Head of Research as of 1 August 2026. In her role, she will lead the 35 research groups and join the Executive Team. With this… More...
17.04.2026
Impactful Communication for Impactful Science – Farewell Symposium of Nicole Probst-Hensch
How can scientific evidence reach people and translate into meaningful improvements in public health? This question was at the heart of today’s symposium on Impactful Communication… More...
07.04.2026
The sleeping beast: Tackling diseases in their dormant stages
Swiss TPH is announcing a symposium on one of the most persistent challenges in medicine: diseases that evade treatment by entering a dormant state. “The Sleeping Beast: Tackling… More...
01.04.2026
Christoph Rösli appointed Head of Platforms
Christoph Rösli joins Swiss TPH as the new Head of Platforms. In his role, he will lead the scientific platforms and core facilities and join the Executive Team of Swiss TPH. With… More...
24.03.2026
Ending TB: From innovation to impact
Tuberculosis (TB) remains one of the world’s deadliest infectious diseases. In 2024 alone, an estimated 10.7 million people fell ill with TB and 1.23 million died. Yet progress is… More...
10.03.2026
EEA policy brief highlights link between pollution and mental health
A comprehensive evidence review conducted by Swiss TPH and the German Environment Agency (UBA) has informed a new policy brief by the European Environment Agency (EEA) on the links… More...
06.03.2026
Expert comment: pollen season has started in Switzerland
As temperatures get warmer, allergy sufferers are among the first to notice. This year’s pollen season is already under way – much earlier than usual – and it is only going to… More...
05.03.2026
Digital parenting support improves early childhood development in rural Peru
A new Swiss TPH-led study shows how digital tools can support caregivers and extend early childhood development services in resource-constrained settings. Conducted in rural Peru,… More...
04.03.2026
Milestone towards eliminating sleeping sickness
The European Medicines Agency has issued a positive opinion for Acoziborole Winthrop, a single-dose oral treatment for T.b. gambiense, the most common form of sleeping sickness.… More...
27.02.2026
Digital decision support tool reduces antibiotic prescription by more than 60%
Antibiotic overuse in primary care remains a major driver of antimicrobial resistance, particularly in settings where diagnostic uncertainty is high. A large study in Rwanda,… More...
20.02.2026
Expert comment: Chikungunya transmission risk in Switzerland
A study published this week found that chikungunya virus can be transmitted by the Asian tiger mosquito at temperatures as low as 13-14°C – lower than previously estimated, which… More...
06.01.2026
Parents’ activity patterns shape children for years, cohort data show
New long-term data reveal that parents who sit less and move more have children who are more active – and this influence persists for years. The study provides evidence on how… More...
10.12.2025
Scientists Achieve Landmark Breakthrough in the Fight Against Malaria
In a landmark study published in Nature today, scientists from the Ifakara Health Institute (IHI) and the National Institute for Medical Research (NIMR) in Tanzania, in partnership… More...
26.11.2025
Longitudinal Study Analyses Mental Health in Gaza from 2020 to 2025
A long-term cohort study found that severe psychological distress among adults in Gaza has more than tripled since the outbreak of war in October 2023. The study by Swiss TPH and… More...
25.11.2025
European Initiative Advances Digital Twin Technology for Cleaner, Healthier Cities
A new European initiative, HARMONIE, will develop advanced digital twin tools to help cities reduce air and noise pollution and better assess their impact on public health. The… More...
19.11.2025
Promising Non-Artemisinin Malaria Drug Succeeds in Phase III Trial
Last week, Novartis and Medicines for Malaria Venture (MMV) announced that their candidate drug GanLum (ganaplacide/lumefantrine, or KLU156) met its primary endpoint in a Phase III… More...
04.11.2025
New Project to Strengthen Ukraine’s Rehabilitation System
Today, the four-year Swiss-Ukrainian project “TRUE – Trauma Rehabilitation for Ukraine” has been launched with the aim of further strengthening the rehabilitation system in the… More...
28.10.2025
Promising Malaria Vaccine Candidate Boosts Immunity in Adults Living in Endemic Regions
SUM-101, a new malaria vaccine candidate has shown to be safe and to trigger strong immune responses in adults living in a malaria-endemic region of Tanzania. The study, conducted… More...